Intersect ENT chooses Dialog as its EU MDR literature research tool

Dialog News, EU MDR

May 26, 2021

We are delighted to announce that medical technology company Intersect ENT has chosen Dialog Solutions to help it conduct EU MDR literature research for its EU MDR Clinical Evaluation Reports.

Intersect ENT is dedicated to advancing the treatment of ear, nose, and throat (ENT) conditions through evidence-based innovation. As a medical device manufacturer, it must comply with the EU’s Medical Device Regulation, which comes into force in May 2021. A key part of this is performing literature reviews to complete various sections of Clinical Evaluation Reports, including current knowledge and state of the art, clinical literature, post-marketing surveillance, adverse events and device comparison.

Using the Dialog platform, Intersect ENT is able to search multiple databases at once for its EU MDR literature research. These databases include Embase and Medline, plus other valuable sources such as grey literature and technical papers. As well as taking advantage of a cost-effective pricing model for multiple databases, Intersect ENT will be able to make its literature searches more efficient thanks to Dialog’s saved search feature, alerts manager and precision search functionality.

Michael Rai, General Manager at Dialog Solutions, explains more “With the EU MDR placing more stringent reporting obligations on medical device manufacturers, having an efficient and cost-effective approach to literature searching is vital. Dialog offers manufacturers everything they need to comprehensively search a huge range of databases for their Clinical Evaluation Reports. We’re looking forward to working with Intersect ENT and helping it with its EU MDR literature research.”

Find out more about how we are helping medical device manufacturers meet their EU MDR reporting obligations – click here.

Embase vs MEDLINE: FAQ

Whether you're conducting a systematic review literature search or screening literature for drug...